RNA-Seq analysis of early transcriptional responses to activation in the leukaemic Jurkat E6.1 T cell line

Wellcome Open Res. 2021 Jun 17:5:42. doi: 10.12688/wellcomeopenres.15748.2. eCollection 2020.

Abstract

Background: The leukaemia-derived Jurkat E6.1 cell line has been used as a model T cell in the study of many aspects of T cell biology, most notably activation in response to T cell receptor (TCR) engagement. Methods: We present whole-transcriptome RNA-Sequencing data for Jurkat E6.1 cells in the resting state and two hours post-activation via TCR and CD28. We compare early transcriptional responses in the presence and absence of the chemokines CXCL12 and CCL19, and perform a basic comparison between observed transcriptional responses in Jurkat E6.1 cells and those in primary human T cells using publicly deposited data. Results: Jurkat E6.1 cells have many of the hallmarks of standard T cell transcriptional responses to activation, but lack most of the depth of responses in primary cells. Conclusions: These data indicate that Jurkat E6.1 cells hence represent only a highly simplified model of early T cell transcriptional responses.

Keywords: Chemokines; Jurkats; RNA-Seq; T cell activation.

Grants and funding

This work was supported by the Wellcome Trust through a Sir Henry Wellcome Postdoctoral Fellowship to J.H.F. (107375) and a Wellcome Trust Principal Research Fellowship to M.L.D (100262). S.L.F. and G.F. received funding from the Innovative Medicines Initiative (EU/EFPIA, ULTRA-DD grant no. 115766).